ClinicalTrials.govpublic full text
Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma
advanced hepatocellular carcinoma, oligometastasis, ablation, anti-pd1 antibody, lenvatinib, lenvatinb, tislelizumab, sintilimab, camrelizumab, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 880736
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.